HEADER IMMUNE SYSTEM 22-MAY-18 6GL3 TITLE CRYSTAL STRUCTURE OF HUMAN PHOSPHATIDYLINOSITOL 4-KINASE III BETA TITLE 2 (PI4KIIIBETA) IN COMPLEX WITH LIGAND 44 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 4-KINASE BETA,PHOSPHATIDYLINOSITOL 4- COMPND 3 KINASE BETA; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: PTDINS 4-KINASE BETA,NPIK,PI4K92,PTDINS 4-KINASE BETA,NPIK, COMPND 6 PI4K92; COMPND 7 EC: 2.7.1.67,2.7.1.67; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PI4KB, PIK4CB; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PI4K KINASE, IMMUNOSUPPRESSIVE, PHOSPHOINOSITOL 4-KINASE IIIBETA, KEYWDS 2 TRANSPLANTATION, HUMAN MIXED LYMPHOCYTE REACTION, SELECTIVITY KEYWDS 3 PROFILE, BINDING MODE, SOLUBILITY, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR A.LAMMENS,M.AUGUSTIN,S.STEINBACHER,J.REUBERSON REVDAT 3 15-MAY-24 6GL3 1 REMARK REVDAT 2 22-AUG-18 6GL3 1 JRNL REVDAT 1 15-AUG-18 6GL3 0 JRNL AUTH J.REUBERSON,H.HORSLEY,R.J.FRANKLIN,D.FORD,J.NEUSS, JRNL AUTH 2 D.BROOKINGS,Q.HUANG,B.VANDERHOYDONCK,L.J.GAO,M.Y.JANG, JRNL AUTH 3 P.HERDEWIJN,A.GHAWALKAR,F.FALLAH-ARANI,A.R.KHAN,J.HENSHALL, JRNL AUTH 4 M.JAIRAJ,S.MALCOLM,E.WARD,L.SHUTTLEWORTH,Y.LIN,S.LI,T.LOUAT, JRNL AUTH 5 M.WAER,J.HERMAN,A.PAYNE,T.CESKA,C.DOYLE,W.PITT,M.CALMIANO, JRNL AUTH 6 M.AUGUSTIN,S.STEINBACHER,A.LAMMENS,R.ALLEN JRNL TITL DISCOVERY OF A POTENT, ORALLY BIOAVAILABLE PI4KIII BETA JRNL TITL 2 INHIBITOR (UCB9608) ABLE TO SIGNIFICANTLY PROLONG ALLOGENEIC JRNL TITL 3 ORGAN ENGRAFTMENT IN VIVO. JRNL REF J. MED. CHEM. V. 61 6705 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29952567 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00521 REMARK 2 REMARK 2 RESOLUTION. 2.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.77 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 86.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 742 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.278 REMARK 3 R VALUE (WORKING SET) : 0.276 REMARK 3 FREE R VALUE : 0.333 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5288 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 15 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GL3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1200010167. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19839 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.770 REMARK 200 RESOLUTION RANGE LOW (A) : 86.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.0500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.720 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM CITRATE, 22% (W/V) REMARK 280 PEG3350, 10 MM MANGANESE(II)CHLORIDE, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.23400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 86.42000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.74200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 86.42000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.23400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.74200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 316 REMARK 465 SER A 317 REMARK 465 SER A 318 REMARK 465 PRO A 319 REMARK 465 VAL A 320 REMARK 465 ARG A 321 REMARK 465 LEU A 322 REMARK 465 ARG A 519 REMARK 465 ILE A 520 REMARK 465 ARG A 521 REMARK 465 SER A 522 REMARK 465 THR A 523 REMARK 465 ARG A 524 REMARK 465 SER A 525 REMARK 465 ASP A 526 REMARK 465 SER A 527 REMARK 465 GLY A 528 REMARK 465 ASP A 529 REMARK 465 GLY A 530 REMARK 465 SER A 531 REMARK 465 ALA A 532 REMARK 465 LEU A 533 REMARK 465 LYS A 534 REMARK 465 SER A 697 REMARK 465 PRO A 698 REMARK 465 ARG A 699 REMARK 465 ASN A 700 REMARK 465 LEU A 701 REMARK 465 GLY A 702 REMARK 465 PHE A 703 REMARK 465 GLU A 704 REMARK 465 ARG A 798 REMARK 465 GLY B 316 REMARK 465 SER B 317 REMARK 465 SER B 318 REMARK 465 PRO B 319 REMARK 465 VAL B 320 REMARK 465 ARG B 321 REMARK 465 LEU B 322 REMARK 465 ALA B 323 REMARK 465 PRO B 324 REMARK 465 GLU B 325 REMARK 465 ARG B 326 REMARK 465 GLU B 327 REMARK 465 GLY B 336 REMARK 465 LYS B 337 REMARK 465 ARG B 338 REMARK 465 LEU B 339 REMARK 465 ALA B 340 REMARK 465 THR B 341 REMARK 465 LYS B 345 REMARK 465 GLU B 346 REMARK 465 GLN B 347 REMARK 465 LYS B 348 REMARK 465 THR B 349 REMARK 465 GLN B 350 REMARK 465 ARG B 351 REMARK 465 LEU B 352 REMARK 465 ILE B 353 REMARK 465 SER B 354 REMARK 465 GLU B 355 REMARK 465 LEU B 356 REMARK 465 SER B 357 REMARK 465 LEU B 358 REMARK 465 LEU B 359 REMARK 465 ASN B 360 REMARK 465 VAL B 387 REMARK 465 VAL B 388 REMARK 465 LEU B 389 REMARK 465 ASN B 390 REMARK 465 SER B 391 REMARK 465 LYS B 392 REMARK 465 ASP B 393 REMARK 465 ASP B 410 REMARK 465 THR B 411 REMARK 465 THR B 412 REMARK 465 ALA B 513 REMARK 465 ARG B 514 REMARK 465 ILE B 515 REMARK 465 PRO B 516 REMARK 465 GLU B 517 REMARK 465 ASN B 518 REMARK 465 ARG B 519 REMARK 465 ILE B 520 REMARK 465 ARG B 521 REMARK 465 SER B 522 REMARK 465 THR B 523 REMARK 465 ARG B 524 REMARK 465 SER B 525 REMARK 465 ASP B 526 REMARK 465 SER B 527 REMARK 465 GLY B 528 REMARK 465 ASP B 529 REMARK 465 GLY B 530 REMARK 465 SER B 531 REMARK 465 ALA B 532 REMARK 465 LEU B 533 REMARK 465 LYS B 534 REMARK 465 GLU B 535 REMARK 465 PRO B 612 REMARK 465 VAL B 613 REMARK 465 VAL B 614 REMARK 465 ASN B 615 REMARK 465 GLY B 639 REMARK 465 SER B 640 REMARK 465 SER B 695 REMARK 465 SER B 696 REMARK 465 SER B 697 REMARK 465 PRO B 698 REMARK 465 ARG B 699 REMARK 465 ASN B 700 REMARK 465 LEU B 701 REMARK 465 GLY B 702 REMARK 465 PHE B 703 REMARK 465 GLU B 704 REMARK 465 THR B 705 REMARK 465 SER B 706 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 330 CE NZ REMARK 480 LYS A 337 CE NZ REMARK 480 GLU A 346 CD OE1 OE2 REMARK 480 LEU A 358 CG CD1 CD2 REMARK 480 LYS A 362 CE NZ REMARK 480 LYS A 392 CG CD CE NZ REMARK 480 ASP A 393 CG OD1 OD2 REMARK 480 LYS A 394 CG CD CE NZ REMARK 480 GLN A 538 CD OE1 NE2 REMARK 480 LYS A 540 NZ REMARK 480 ARG A 542 NE CZ NH1 NH2 REMARK 480 LYS A 564 NZ REMARK 480 GLN A 588 CG CD OE1 NE2 REMARK 480 ARG A 590 CG CD NE CZ NH1 NH2 REMARK 480 LYS A 596 NZ REMARK 480 GLN A 621 CD OE1 NE2 REMARK 480 GLN A 625 CG CD OE1 NE2 REMARK 480 GLU A 644 CG CD OE1 OE2 REMARK 480 LYS A 670 CD CE NZ REMARK 480 SER A 695 OG REMARK 480 LYS A 709 CE NZ REMARK 480 ASP A 722 CG OD1 OD2 REMARK 480 ASP A 724 CG OD1 OD2 REMARK 480 ASN A 727 CG OD1 ND2 REMARK 480 LYS A 730 CD CE NZ REMARK 480 LEU A 734 CD1 CD2 REMARK 480 LYS A 742 CD CE NZ REMARK 480 ASP A 745 CG OD1 OD2 REMARK 480 LYS A 746 CG CD CE NZ REMARK 480 VAL A 747 CG1 CG2 REMARK 480 ILE A 753 CD1 REMARK 480 SER A 758 OG REMARK 480 GLN A 759 CG CD OE1 NE2 REMARK 480 LEU A 760 CG CD1 CD2 REMARK 480 HIS A 764 CG ND1 CD2 CE1 NE2 REMARK 480 SER A 766 OG REMARK 480 ARG A 770 CG CD NE CZ NH1 NH2 REMARK 480 LYS A 773 CG CD CE NZ REMARK 480 GLU A 774 CG CD OE1 OE2 REMARK 480 GLU A 783 CG CD OE1 OE2 REMARK 480 GLN A 784 CG CD OE1 NE2 REMARK 480 GLN A 786 CG CD OE1 NE2 REMARK 480 LEU A 787 CD1 CD2 REMARK 480 LEU A 788 CG CD1 CD2 REMARK 480 ILE B 329 CG1 CG2 CD1 REMARK 480 LYS B 330 CG CD CE NZ REMARK 480 MET B 333 CG SD CE REMARK 480 ILE B 335 CG1 CG2 CD1 REMARK 480 ARG B 366 CG CD NE CZ NH1 NH2 REMARK 480 TRP B 368 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 480 TRP B 368 CZ3 CH2 REMARK 480 HIS B 383 CG ND1 CD2 CE1 NE2 REMARK 480 ILE B 399 CG1 CG2 CD1 REMARK 480 VAL B 401 CG1 CG2 REMARK 480 LEU B 404 CG CD1 CD2 REMARK 480 GLU B 405 CG CD OE1 OE2 REMARK 480 GLU B 407 CG CD OE1 OE2 REMARK 480 ASN B 408 CG OD1 ND2 REMARK 480 GLU B 539 CG CD OE1 OE2 REMARK 480 LYS B 540 CG CD CE NZ REMARK 480 VAL B 541 CG1 CG2 REMARK 480 ARG B 542 CG CD NE CZ NH1 NH2 REMARK 480 LYS B 564 CG CD CE NZ REMARK 480 LEU B 569 CG CD1 CD2 REMARK 480 LYS B 580 CG CD CE NZ REMARK 480 GLN B 581 CG CD OE1 NE2 REMARK 480 ILE B 585 CD1 REMARK 480 GLU B 587 CD OE1 OE2 REMARK 480 GLN B 588 CG CD OE1 NE2 REMARK 480 ARG B 590 CG CD NE CZ NH1 NH2 REMARK 480 LYS B 596 CD CE NZ REMARK 480 LYS B 599 CG CD CE NZ REMARK 480 GLN B 621 CG CD OE1 NE2 REMARK 480 LYS B 624 CG CD CE NZ REMARK 480 GLN B 625 CD OE1 NE2 REMARK 480 LEU B 635 CG CD1 CD2 REMARK 480 GLN B 636 CD OE1 NE2 REMARK 480 GLU B 637 CD OE1 OE2 REMARK 480 TYR B 641 CG CD1 CD2 CE1 CE2 CZ OH REMARK 480 THR B 642 OG1 CG2 REMARK 480 GLU B 644 CG CD OE1 OE2 REMARK 480 LEU B 647 CG CD1 CD2 REMARK 480 LYS B 670 CE NZ REMARK 480 LEU B 679 CG CD1 CD2 REMARK 480 PHE B 692 CG CD1 CD2 CE1 CE2 CZ REMARK 480 LYS B 709 CG CD CE NZ REMARK 480 LEU B 721 CG CD1 CD2 REMARK 480 ASP B 724 CG OD1 OD2 REMARK 480 MET B 725 CG SD CE REMARK 480 ASN B 727 CG OD1 ND2 REMARK 480 GLN B 735 CG CD OE1 NE2 REMARK 480 ILE B 738 CG1 CG2 CD1 REMARK 480 LYS B 742 CG CD CE NZ REMARK 480 LYS B 746 CD CE NZ REMARK 480 VAL B 747 CG1 CG2 REMARK 480 LEU B 760 CG CD1 CD2 REMARK 480 LYS B 773 CG CD CE NZ REMARK 480 GLU B 783 CG CD OE1 OE2 REMARK 480 GLN B 786 CG CD OE1 NE2 REMARK 480 LEU B 787 CG CD1 CD2 REMARK 480 LEU B 788 CG CD1 CD2 REMARK 480 GLU B 790 CG CD OE1 OE2 REMARK 480 MET B 792 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR B 641 CB - CG - CD2 ANGL. DEV. = 4.6 DEGREES REMARK 500 TYR B 641 CB - CG - CD1 ANGL. DEV. = -4.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 393 -64.68 -103.57 REMARK 500 ALA A 395 75.30 -115.20 REMARK 500 PRO A 592 44.02 -88.35 REMARK 500 ASP A 689 63.55 61.50 REMARK 500 PHE A 690 45.92 -82.96 REMARK 500 LEU A 694 -127.06 60.68 REMARK 500 SER A 706 15.56 56.61 REMARK 500 GLN A 759 69.04 -117.02 REMARK 500 HIS A 764 50.53 -90.49 REMARK 500 HIS A 777 63.44 60.20 REMARK 500 CYS B 565 147.67 -170.20 REMARK 500 PRO B 592 45.03 -88.37 REMARK 500 ASP B 689 63.61 60.59 REMARK 500 PHE B 690 46.05 -82.80 REMARK 500 MET B 797 63.58 -101.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EMW A 801 DBREF 6GL3 A 317 525 UNP Q9UBF8 PI4KB_HUMAN 317 428 DBREF 6GL3 A 532 798 UNP Q9UBF8 PI4KB_HUMAN 532 798 DBREF 6GL3 B 317 525 UNP Q9UBF8 PI4KB_HUMAN 317 428 DBREF 6GL3 B 532 798 UNP Q9UBF8 PI4KB_HUMAN 532 798 SEQADV 6GL3 GLY A 316 UNP Q9UBF8 EXPRESSION TAG SEQADV 6GL3 ASP A 526 UNP Q9UBF8 LINKER SEQADV 6GL3 SER A 527 UNP Q9UBF8 LINKER SEQADV 6GL3 GLY A 528 UNP Q9UBF8 LINKER SEQADV 6GL3 ASP A 529 UNP Q9UBF8 LINKER SEQADV 6GL3 GLY A 530 UNP Q9UBF8 LINKER SEQADV 6GL3 SER A 531 UNP Q9UBF8 LINKER SEQADV 6GL3 GLY B 316 UNP Q9UBF8 EXPRESSION TAG SEQADV 6GL3 ASP B 526 UNP Q9UBF8 LINKER SEQADV 6GL3 SER B 527 UNP Q9UBF8 LINKER SEQADV 6GL3 GLY B 528 UNP Q9UBF8 LINKER SEQADV 6GL3 ASP B 529 UNP Q9UBF8 LINKER SEQADV 6GL3 GLY B 530 UNP Q9UBF8 LINKER SEQADV 6GL3 SER B 531 UNP Q9UBF8 LINKER SEQRES 1 A 386 GLY SER SER PRO VAL ARG LEU ALA PRO GLU ARG GLU PHE SEQRES 2 A 386 ILE LYS SER LEU MET ALA ILE GLY LYS ARG LEU ALA THR SEQRES 3 A 386 LEU PRO THR LYS GLU GLN LYS THR GLN ARG LEU ILE SER SEQRES 4 A 386 GLU LEU SER LEU LEU ASN HIS LYS LEU PRO ALA ARG VAL SEQRES 5 A 386 TRP LEU PRO THR ALA GLY PHE ASP HIS HIS VAL VAL ARG SEQRES 6 A 386 VAL PRO HIS THR GLN ALA VAL VAL LEU ASN SER LYS ASP SEQRES 7 A 386 LYS ALA PRO TYR LEU ILE TYR VAL GLU VAL LEU GLU CYS SEQRES 8 A 386 GLU ASN PHE ASP THR THR SER VAL PRO ALA ARG ILE PRO SEQRES 9 A 386 GLU ASN ARG ILE ARG SER THR ARG SER ASP SER GLY ASP SEQRES 10 A 386 GLY SER ALA LEU LYS GLU PRO TRP GLN GLU LYS VAL ARG SEQRES 11 A 386 ARG ILE ARG GLU GLY SER PRO TYR GLY HIS LEU PRO ASN SEQRES 12 A 386 TRP ARG LEU LEU SER VAL ILE VAL LYS CYS GLY ASP ASP SEQRES 13 A 386 LEU ARG GLN GLU LEU LEU ALA PHE GLN VAL LEU LYS GLN SEQRES 14 A 386 LEU GLN SER ILE TRP GLU GLN GLU ARG VAL PRO LEU TRP SEQRES 15 A 386 ILE LYS PRO TYR LYS ILE LEU VAL ILE SER ALA ASP SER SEQRES 16 A 386 GLY MET ILE GLU PRO VAL VAL ASN ALA VAL SER ILE HIS SEQRES 17 A 386 GLN VAL LYS LYS GLN SER GLN LEU SER LEU LEU ASP TYR SEQRES 18 A 386 PHE LEU GLN GLU HIS GLY SER TYR THR THR GLU ALA PHE SEQRES 19 A 386 LEU SER ALA GLN ARG ASN PHE VAL GLN SER CYS ALA GLY SEQRES 20 A 386 TYR CYS LEU VAL CYS TYR LEU LEU GLN VAL LYS ASP ARG SEQRES 21 A 386 HIS ASN GLY ASN ILE LEU LEU ASP ALA GLU GLY HIS ILE SEQRES 22 A 386 ILE HIS ILE ASP PHE GLY PHE ILE LEU SER SER SER PRO SEQRES 23 A 386 ARG ASN LEU GLY PHE GLU THR SER ALA PHE LYS LEU THR SEQRES 24 A 386 THR GLU PHE VAL ASP VAL MET GLY GLY LEU ASP GLY ASP SEQRES 25 A 386 MET PHE ASN TYR TYR LYS MET LEU MET LEU GLN GLY LEU SEQRES 26 A 386 ILE ALA ALA ARG LYS HIS MET ASP LYS VAL VAL GLN ILE SEQRES 27 A 386 VAL GLU ILE MET GLN GLN GLY SER GLN LEU PRO CYS PHE SEQRES 28 A 386 HIS GLY SER SER THR ILE ARG ASN LEU LYS GLU ARG PHE SEQRES 29 A 386 HIS MET SER MET THR GLU GLU GLN LEU GLN LEU LEU VAL SEQRES 30 A 386 GLU GLN MET VAL ASP GLY SER MET ARG SEQRES 1 B 386 GLY SER SER PRO VAL ARG LEU ALA PRO GLU ARG GLU PHE SEQRES 2 B 386 ILE LYS SER LEU MET ALA ILE GLY LYS ARG LEU ALA THR SEQRES 3 B 386 LEU PRO THR LYS GLU GLN LYS THR GLN ARG LEU ILE SER SEQRES 4 B 386 GLU LEU SER LEU LEU ASN HIS LYS LEU PRO ALA ARG VAL SEQRES 5 B 386 TRP LEU PRO THR ALA GLY PHE ASP HIS HIS VAL VAL ARG SEQRES 6 B 386 VAL PRO HIS THR GLN ALA VAL VAL LEU ASN SER LYS ASP SEQRES 7 B 386 LYS ALA PRO TYR LEU ILE TYR VAL GLU VAL LEU GLU CYS SEQRES 8 B 386 GLU ASN PHE ASP THR THR SER VAL PRO ALA ARG ILE PRO SEQRES 9 B 386 GLU ASN ARG ILE ARG SER THR ARG SER ASP SER GLY ASP SEQRES 10 B 386 GLY SER ALA LEU LYS GLU PRO TRP GLN GLU LYS VAL ARG SEQRES 11 B 386 ARG ILE ARG GLU GLY SER PRO TYR GLY HIS LEU PRO ASN SEQRES 12 B 386 TRP ARG LEU LEU SER VAL ILE VAL LYS CYS GLY ASP ASP SEQRES 13 B 386 LEU ARG GLN GLU LEU LEU ALA PHE GLN VAL LEU LYS GLN SEQRES 14 B 386 LEU GLN SER ILE TRP GLU GLN GLU ARG VAL PRO LEU TRP SEQRES 15 B 386 ILE LYS PRO TYR LYS ILE LEU VAL ILE SER ALA ASP SER SEQRES 16 B 386 GLY MET ILE GLU PRO VAL VAL ASN ALA VAL SER ILE HIS SEQRES 17 B 386 GLN VAL LYS LYS GLN SER GLN LEU SER LEU LEU ASP TYR SEQRES 18 B 386 PHE LEU GLN GLU HIS GLY SER TYR THR THR GLU ALA PHE SEQRES 19 B 386 LEU SER ALA GLN ARG ASN PHE VAL GLN SER CYS ALA GLY SEQRES 20 B 386 TYR CYS LEU VAL CYS TYR LEU LEU GLN VAL LYS ASP ARG SEQRES 21 B 386 HIS ASN GLY ASN ILE LEU LEU ASP ALA GLU GLY HIS ILE SEQRES 22 B 386 ILE HIS ILE ASP PHE GLY PHE ILE LEU SER SER SER PRO SEQRES 23 B 386 ARG ASN LEU GLY PHE GLU THR SER ALA PHE LYS LEU THR SEQRES 24 B 386 THR GLU PHE VAL ASP VAL MET GLY GLY LEU ASP GLY ASP SEQRES 25 B 386 MET PHE ASN TYR TYR LYS MET LEU MET LEU GLN GLY LEU SEQRES 26 B 386 ILE ALA ALA ARG LYS HIS MET ASP LYS VAL VAL GLN ILE SEQRES 27 B 386 VAL GLU ILE MET GLN GLN GLY SER GLN LEU PRO CYS PHE SEQRES 28 B 386 HIS GLY SER SER THR ILE ARG ASN LEU LYS GLU ARG PHE SEQRES 29 B 386 HIS MET SER MET THR GLU GLU GLN LEU GLN LEU LEU VAL SEQRES 30 B 386 GLU GLN MET VAL ASP GLY SER MET ARG HET EMW A 801 30 HETNAM EMW (3~{S})-4-(6-AZANYL-1-METHYL-PYRAZOLO[3,4-D]PYRIMIDIN- HETNAM 2 EMW 4-YL)-~{N}-(4-METHOXY-2-METHYL-PHENYL)-3-METHYL- HETNAM 3 EMW PIPERAZINE-1-CARBOXAMIDE FORMUL 3 EMW C20 H26 N8 O2 FORMUL 4 HOH *15(H2 O) HELIX 1 AA1 ALA A 323 GLU A 325 5 3 HELIX 2 AA2 ARG A 326 ALA A 340 1 15 HELIX 3 AA3 THR A 344 ASN A 360 1 17 HELIX 4 AA4 PRO A 382 ALA A 386 5 5 HELIX 5 AA5 PRO A 536 SER A 548 1 13 HELIX 6 AA6 LEU A 569 GLU A 589 1 21 HELIX 7 AA7 ILE A 619 GLN A 627 1 9 HELIX 8 AA8 SER A 629 HIS A 638 1 10 HELIX 9 AA9 THR A 643 GLN A 668 1 26 HELIX 10 AB1 THR A 711 MET A 718 1 8 HELIX 11 AB2 GLY A 723 HIS A 743 1 21 HELIX 12 AB3 HIS A 743 GLN A 756 1 14 HELIX 13 AB4 SER A 766 ARG A 775 1 10 HELIX 14 AB5 THR A 781 MET A 797 1 17 HELIX 15 AB6 ILE B 329 ILE B 335 1 7 HELIX 16 AB7 TRP B 537 SER B 548 1 12 HELIX 17 AB8 LEU B 569 GLU B 589 1 21 HELIX 18 AB9 ILE B 619 GLN B 627 1 9 HELIX 19 AC1 SER B 629 HIS B 638 1 10 HELIX 20 AC2 THR B 643 GLN B 668 1 26 HELIX 21 AC3 THR B 711 MET B 718 1 8 HELIX 22 AC4 GLY B 723 HIS B 743 1 21 HELIX 23 AC5 HIS B 743 GLN B 756 1 14 HELIX 24 AC6 PRO B 761 ARG B 775 1 15 HELIX 25 AC7 THR B 781 MET B 797 1 17 SHEET 1 AA1 3 HIS A 376 ARG A 380 0 SHEET 2 AA1 3 TYR A 397 GLU A 405 -1 O GLU A 402 N ARG A 380 SHEET 3 AA1 3 VAL A 387 VAL A 388 -1 N VAL A 387 O LEU A 398 SHEET 1 AA2 5 HIS A 376 ARG A 380 0 SHEET 2 AA2 5 TYR A 397 GLU A 405 -1 O GLU A 402 N ARG A 380 SHEET 3 AA2 5 TRP A 556 CYS A 565 -1 O VAL A 563 N TYR A 397 SHEET 4 AA2 5 SER A 607 ILE A 610 -1 O ILE A 610 N ILE A 562 SHEET 5 AA2 5 ILE A 600 SER A 604 -1 N LEU A 601 O MET A 609 SHEET 1 AA3 3 ALA A 616 SER A 618 0 SHEET 2 AA3 3 ILE A 677 ASP A 680 -1 O LEU A 679 N VAL A 617 SHEET 3 AA3 3 ILE A 685 HIS A 687 -1 O ILE A 686 N LEU A 678 SHEET 1 AA4 5 HIS B 376 ARG B 380 0 SHEET 2 AA4 5 TYR B 397 GLU B 405 -1 O GLU B 402 N ARG B 380 SHEET 3 AA4 5 TRP B 556 VAL B 563 -1 O VAL B 563 N TYR B 397 SHEET 4 AA4 5 SER B 607 ILE B 610 -1 O ILE B 610 N ILE B 562 SHEET 5 AA4 5 ILE B 600 SER B 604 -1 N LEU B 601 O MET B 609 SHEET 1 AA5 3 VAL B 617 SER B 618 0 SHEET 2 AA5 3 ILE B 677 LEU B 679 -1 O LEU B 679 N VAL B 617 SHEET 3 AA5 3 ILE B 685 HIS B 687 -1 O ILE B 686 N LEU B 678 CISPEP 1 LEU A 363 PRO A 364 0 -2.94 CISPEP 2 LEU B 363 PRO B 364 0 -1.08 SITE 1 AC1 13 ASN A 390 GLU A 405 ARG A 557 ILE A 562 SITE 2 AC1 13 TYR A 598 GLU A 611 PRO A 612 VAL A 613 SITE 3 AC1 13 ALA A 616 HIS A 620 GLY A 675 LEU A 678 SITE 4 AC1 13 ILE A 688 CRYST1 64.468 69.484 172.840 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015512 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014392 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005786 0.00000